This opportunity funds P50 SPORE grants supporting investigator-initiated translational research on human cancers, focusing on organ-specific or biologically related groups of cancers. Projects must include clinical trials and aim to achieve translational human endpoints within the grant period. Research areas include prevention, early detection, diagnosis, and treatment, with flexibility for cross-cutting themes such as pediatric cancers or health disparities.
Eligible applicants include a wide range of organizations such as independent school districts, tribal organizations, small businesses, governments, nonprofits, and institutions of higher education, both public and private. Eligibility is broad and includes for-profit organizations other than small
